Cerebramha

    Get in touch
    with our team

    Cerebramha turns a standard brain MRI into a quantitative, clinician-ready report measuring ten brain regions in under five minutes. Cedawn, the Alzheimer's platform, is live; Brain Tumour Segmentation is in development.

    • Built for clinicians, researchers and institutions, not for patient use.
    • Neither Cedawn nor Brain Tumour Segmentation is cleared for diagnostic use.
    • No scans, DICOM or NIfTI files, medical records or patient identifiers.

    Please do not include patient data, scans or identifiers.

    Connect with our team

    Clinicians and radiologists

    See how a quantitative volumetric report sits inside an existing read. Cedawn, the Alzheimer's platform, is live today.

    Write to us

    Researchers

    Neurodegeneration, longitudinal cohorts and normative modelling. The research API is not open yet, so start with study design.

    Discuss a study

    Institutions and press

    Hospitals and imaging centres weighing what an integration would involve. Journalists with questions about the company or its products.

    Ask a question

    All three reach contact@cerebramha.com.

    Frequently asked questions

    What the analysis needs, what it measures, and where the two products stand today.

    CereBramha is built around standard medical imaging formats, taking a standard brain MRI from any clinical scanner. No special hardware or preparation is required.

    No. Clinical markers are optional and can be attached alongside the study; the analysis itself runs on the brain MRI.

    Ten clinically relevant regions: the hippocampus, entorhinal cortex, amygdala, inferior temporal gyrus, frontal lobe, parietal lobe, posterior cingulate, precuneus, thalamus, and cerebellum. Each is measured volumetrically and compared against normative data matched by age and sex.

    Under 5 minutes from upload to a quantitative volumetric report.

    Partly. Cedawn, the Alzheimer's platform, is live at cedawn.cerebramha.com. Brain Tumour Segmentation is in development. Neither is cleared for diagnostic use, and the research API is not open yet. Clinicians and researchers can reach the team through the contact form.

    Build the future of clinical AI
    with Cerebramha.